Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205


Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?

Lee YT, Kuo SC, Yang SP, Lin YT, Chiang DH, Tseng FC, Chen TL, Fung CP.

Clin Microbiol Infect. 2013 Jul;19(7):640-5. doi: 10.1111/j.1469-0691.2012.03988.x. Epub 2012 Sep 12.


Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.

Kuo SC, Lee YT, Yang SP, Chiang MC, Lin YT, Tseng FC, Chen TL, Fung CP.

Clin Microbiol Infect. 2013 Jul;19(7):634-9. doi: 10.1111/j.1469-0691.2012.03967.x. Epub 2012 Jul 10.


Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?

Yang YS, Lee YT, Huang TW, Sun JR, Kuo SC, Yang CH, Chen TL, Lin JC, Fung CP, Chang FY.

BMC Infect Dis. 2013 Mar 19;13:142. doi: 10.1186/1471-2334-13-142.


Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States.

Wisplinghoff H, Paulus T, Lugenheim M, Stefanik D, Higgins PG, Edmond MB, Wenzel RP, Seifert H.

J Infect. 2012 Mar;64(3):282-90. doi: 10.1016/j.jinf.2011.12.008. Epub 2011 Dec 20.


Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure.

Wang YC, Lee YT, Yang YS, Chen CT, Chiu CH, Yin T, Kuo SC, Chen TL, Lin JC, Wang FD, Fung CP, Chang FY.

Clin Microbiol Infect. 2015 Aug;21(8):758-64. doi: 10.1016/j.cmi.2015.05.005. Epub 2015 May 14.


Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.

Özvatan T, Akalın H, Sınırtaş M, Ocakoğlu G, Yılmaz E, Heper Y, Kelebek N, İşçimen R, Kahveci F.

Respirology. 2016 Feb;21(2):363-9. doi: 10.1111/resp.12698. Epub 2015 Dec 3.


Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.

Yang YS, Lee YT, Tsai WC, Kuo SC, Sun JR, Yang CH, Chen TL, Lin JC, Fung CP, Chang FY.

BMC Infect Dis. 2013 Jul 10;13:311. doi: 10.1186/1471-2334-13-311.


A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols.

Davis JS, McMillan M, Swaminathan A, Kelly JA, Piera KE, Baird RW, Currie BJ, Anstey NM.

Chest. 2014 Oct;146(4):1038-1045. doi: 10.1378/chest.13-3065.


Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.

Lee YT, Kuo SC, Yang SP, Lin YT, Tseng FC, Chen TL, Fung CP.

Clin Infect Dis. 2012 Jul;55(2):209-15. doi: 10.1093/cid/cis385. Epub 2012 Apr 11.


Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.

Zheng YL, Wan YF, Zhou LY, Ye ML, Liu S, Xu CQ, He YQ, Chen JH.

Am J Infect Control. 2013 Jul;41(7):e59-63. doi: 10.1016/j.ajic.2013.01.006. Epub 2013 Mar 21.


Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes.

Lee YC, Huang YT, Tan CK, Kuo YW, Liao CH, Lee PI, Hsueh PR.

J Antimicrob Chemother. 2011 Aug;66(8):1839-46. doi: 10.1093/jac/dkr200. Epub 2011 Jun 8.


The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.

Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M.

J Hosp Infect. 2006 Nov;64(3):282-7. Epub 2006 Aug 22.


Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.

Chiang MC, Kuo SC, Chen SJ, Yang SP, Lee YT, Chen TL, Fung CP.

Infection. 2012 Feb;40(1):19-26. doi: 10.1007/s15010-011-0187-4. Epub 2011 Sep 2.


Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections.

Erbay A, Idil A, Gözel MG, Mumcuoğlu I, Balaban N.

Int J Antimicrob Agents. 2009 Dec;34(6):575-9. doi: 10.1016/j.ijantimicag.2009.07.006. Epub 2009 Sep 8.


Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study.

Magret M, Lisboa T, Martin-Loeches I, Máñez R, Nauwynck M, Wrigge H, Cardellino S, Díaz E, Koulenti D, Rello J; EU-VAP/CAP Study Group.

Crit Care. 2011;15(1):R62. doi: 10.1186/cc10036. Epub 2011 Feb 16.


Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance.

Teng SO, Yen MY, Ou TY, Chen FL, Yu FL, Lee WS.

J Microbiol Immunol Infect. 2015 Oct;48(5):525-30. doi: 10.1016/j.jmii.2014.06.011. Epub 2014 Aug 4.


Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.

Choi IS, Lee YJ, Wi YM, Kwan BS, Jung KH, Hong WP, Kim JM.

Int J Antimicrob Agents. 2016 Aug;48(2):175-80. doi: 10.1016/j.ijantimicag.2016.05.011. Epub 2016 Jul 5.


Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.

Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, Belabbes H, Benbachir M.

J Infect. 2006 Oct;53(4):274-8. Epub 2006 Jan 25.


Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis.

Liu YM, Lee YT, Kuo SC, Chen TL, Liu CP, Liu CE.

J Microbiol Immunol Infect. 2017 Feb;50(1):62-67. doi: 10.1016/j.jmii.2015.01.003. Epub 2015 Jan 30.


Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.

Song JY, Cheong HJ, Choi WS, Heo JY, Noh JY, Kim WJ.

J Med Microbiol. 2011 May;60(Pt 5):605-11. doi: 10.1099/jmm.0.029439-0. Epub 2011 Jan 13.


Supplemental Content

Support Center